Staerk L, Sherer J, Ko D et al (2017) Atrial fibrillation epidemiology, pathophysiology, and clinical outcomes. Circ Res 120(9):1501–1517
Article CAS PubMed PubMed Central Google Scholar
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. ;42:373–498. https://doi.org/10.1093/eurheartj/ehaa612. Erratum in Eur. Heart J. 2021, 42, 507 + 546–547 + 4194
Mahajan R, Brooks AG, Sullivan T, Lim HS, Alasady M, Abed HS, Ganesan AN, Nayyar S, Lau DH, Roberts-Thomson KC et al (2012) Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart 98:1120–1126. https://doi.org/10.1136/heartjnl-2012-301799
Collado FMS, von Buchwald CML, Anderson CK, Madan N, Suradi HS, Huang HD, Jneid H, Kavinsky CJ (2021) Left atrial appendage occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation. J Am Heart Assoc 10:e022274. https://doi.org/10.1161/JAHA.121.022274
Article PubMed PubMed Central Google Scholar
Dudzińska-Szczerba K, Kułakowski P, Michałowska I, Baran J (2022) Association between Left Atrial Appendage Morphology and function and the risk of ischaemic stroke in patients with Atrial Fibrillation. Arrhythmia Electrophysiol Rev 11:e09. https://doi.org/10.15420/aer.2022.08
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr., Ellinor PT Jr., Ezekowitz MD, Field ME, Furie KL, HRS Guideline for the Management of Patients With Atrial Fibrillation (2019) Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 140:e125–e151. https://doi.org/10.1161/cir.0000000000000665Erratum in Circulation 2019 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/A Report of the American College of Cardiology/American Heart Association Task
Holmes DR, Reddy VY, Turi ZG et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542
Article CAS PubMed Google Scholar
Holmes DR Jr., Kar S, Price MJ et al (2014) Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64:1–12
Reddy VY, Sievert H, Halperin J et al (2014) Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312:1988–1998
Reddy VY, Doshi SK, Kar S et al (2017) 5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol 70:2964–2975
Godino C, Melillo F, Bellini B et al (2020) Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non‐valvular atrial fibrillation and high bleeding risk. EuroIntervention 15:1548–1554
Osmancik P, Herman D, Neuzil P et al (2021) Left Atrial Appendage Closure versus Non-warfarin oral anticoagulation in Atrial Fibrillation: 4‐Year outcomes of PRAGUE‐17. J Am Coll Cardiol
January CT, Wann LS, Calkins H et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation 140:e125–e151
Hindricks G, Potpara T, Dagres N, Group ESCSD et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio- thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373–498
Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K et al (2013) Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation 127(6):720–729. https://doi.org/10.1161/CIRCULATIONAHA.112.114389
Reddy VY, Mobius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J et al (2013) Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with Watchman left atrial appendage closure technology). J Am Coll Cardiol 61(25):2551–2556. https://doi.org/10.1016/j.jacc.2013.03.035
Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N (2014) Holmes D PROTECT AF Steering Committee and investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312:1988–1998
Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64:1–12
Boersma LV, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, Pokushalov E, Kische S, Schmitz T, Stein KM (2016) Bergmann MW EWOLUTION investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 37:2465–2474
Article PubMed PubMed Central Google Scholar
Turagam MK, Velagapudi P, Kar S, Holmes D, Reddy VY, Refaat MM, Di Biase L, Al-Ahmed A, Chung MK, Lewalter T, Edgerton J, Cox J, Fisher J, Natale A, Lakkireddy DR (2018) Cardiovascular therapies targeting left atrial appendage. J Am Coll Cardiol 72:448–463
Article PubMed PubMed Central Google Scholar
Hahn RT, Abraham T, Adams MS et al (2013) Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 26:921–964
Alkhouli M, Hijazi ZM, Holmes DR Jr., Rihal CS, Wiegers SE (2018) Intracardiac echocardiography in structural heart disease interventions. JACC Cardiovasc Interv 11:2133–2147
Knobloch K, Yoon U, Vogt PM (2011) Preferred reporting items forsystematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 39(2):91–92
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. https://doi.org/10.1007/s10654-010-9491-z
Iwasawa J, Enomoto Y, Sharma D et al (2016) Implantation of the Watchman Left Atrial Appendage Closure device: a comparison of TEE-Guidance vs ICE-Guidance. Circulation 134:A16647
Hemam ME, Kuroki K, Schurmann PA et al (2019 March) Left Atrial Appendage Closure with the Watchman device using Intracardiac vs Transesophageal Echocardiography: procedural and cost considerations. Heart Rhythm 16(3):334–342
Alkhouli M, Nielsen-Kudsk JE (2022) The Case for Intracardiac Echo to Guide Left Atrial Appendage Closure. Interv Cardiol Clin. ;11(2):153–158. doi: 10.1016/j.iccl.2021.11.007. PMID: 35361460
Gianni C, Horton RP, Della Rocca DG, Mohanty S, Al-Ahmad A, Bassiouny MA, Burkhardt JD, Gallinghouse GJ, Hranitzky PM, Sanchez JE, Natale A (2021) Intracardiac echocardiography- versus transesophageal echocardiography-guided left atrial appendage occlusion with Watchman FLX. J Cardiovasc Electrophysiol. ;32(10):2781–2784. https://doi.org/10.1111/jce.15220. Epub 2021 Sep 5. PMID: 34411376
Zahid S, Gowda S, Hashem A et al (2022) Feasibility and safety of Intracardiac Echocardiography Use in Transcatheter Left Atrial Appendage Closure procedures. J Soc Cardiovasc Angiography Interventions 1:100510
Morcos R, Megaly M, Saad M, Barakat AF, Rubens M, Saxena A, Elbadawi A, Kucharik M, Luna M, Garcia S, Veledar E, Maini B, Khalili H (2022) In-hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure. Catheter Cardiovasc Interv 99(5):1572–1581. https://doi.org/10.1002/ccd.30086Epub 2022 Jan 23. PMID: 35066997
Ferro EG, Alkhouli M, Nair DG et al Intracardiac vs Transesophageal Echocardiography for Left Atrial appendage occlusion with Watchman FLX in the U.S. jacc:clinical electrophysiology 9,no. 12,2023
Berti S, Pastormerlo LE, Santoro G et al (2018) Intracardiac versus transesophageal echocardiographic guidance for left atrial appendage occlusion: the LAAO Italian Multicenter Registry. JACC Cardiovasc Interv 11:1086–1092
Pastormerlo LE, Tondo C, Fassini G, Nicosia A, Ronco F, Contarini M, Giacchi G, Grasso C, Casu G, Romeo MR, Mazzone P, Limite L, Caramanno G, Geraci S, Pagnotta P, Chiarito M, Tamburino C, Berti S (2023) Intra-cardiac versus transesophageal echocardiographic Guidance for Left Atrial appendage occlusion with a Watchman FLX device. J Clin Med 12(20):6658. https://doi.org/10.3390/jcm12206658PMID: 37892796; PMCID: PMC10607018
Article PubMed PubMed Central Google Scholar
Reis L, Paiva L, Costa M, Silva J, Teixeira R, Botelho A, Dinis P, Madeira M, Ribeiro J, Nascimento J, Gonçalves L (2018) Registry of left atrial appendage closure and initial experience with intracardiac echocardiography. Rev Port Cardiol (Engl Ed) 37(9):763–772 English, Portuguese. https://doi.org/10.1016/j.repc.2018.03.009
Grazina A, Fiarresga A, Ramos R et al (2023) Intracardiac echocardiography-guided left atrial appendage occlusion: the path to independence. Rev Port Cardiol 42:847–855
Chu H, Du X, Shen C et al (2020) Left atrial appendage closure with zero fluoroscopic exposure via intracardiac echocardiographic guidance. J Formos Med Assoc 119:1586e1592
留言 (0)